March 2026 in “Actas Dermo-Sifiliográficas” Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.
February 2026 in “Journal of Cutaneous and Aesthetic Surgery” Most emerging dermatological treatments lack strong evidence and require more research.
February 2026 in “Orphanet Journal of Rare Diseases” Most genetic mutations causing hypohidrotic ectodermal dysplasia in Russian patients are found in the EDA gene.
January 2026 in “White Rose Research Online (University of Leeds, The University of Sheffield, University of York)” Most patients with alopecia areata did not achieve lasting hair regrowth despite treatment.
November 2025 in “Cosmetics” Most trichological shampoo ingredients lack strong evidence for effectiveness against hair loss.
Most ingredients in hair loss shampoos lack strong evidence of effectiveness.
Most patients were satisfied with topical finasteride, and few experienced side effects.
July 2025 in “SKIN The Journal of Cutaneous Medicine” Most patients with alopecia areata see significant hair regrowth within 93 days of starting ritlecitinib treatment.
Most students know the causes of hair loss, but many wrongly think heredity isn't one.
March 2025 in “Yemeni Journal For Medical Sciences” Most female students in Aden, Yemen, have low vitamin D levels, causing health issues.
February 2025 in “Diagnostics” Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.
January 2025 in “Tropical Medicine and Health” Most children in orphanages in Fayoum and Giza have skin disorders, mainly noninfectious, and need better hygiene and emotional care.
January 2025 in “BMC Nephrology” Most end-stage renal disease patients in Jordan have skin issues like dryness and itching.
January 2025 in “International Journal of Clinical and Diagnostic Pathology” Most skin adnexal tumors are benign and require histopathological examination for accurate diagnosis.
November 2024 in “Global Journal of Human-Social Science” Most people with metabolic syndrome in Brazil have skin issues, especially if they are morbidly obese.
September 2024 in “Journal of the American Academy of Dermatology” Most patients prefer clinics that play music during procedures.
September 2024 in “Journal of the American Academy of Dermatology” Most U.S. keratinocyte carcinoma patients are older white males living in urban areas.
August 2024 in “Medicine” Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.
July 2024 in “Journal of Investigative Dermatology” Most women continued using oral minoxidil for hair loss despite mild to moderate side effects.
June 2024 in “Kushtia Medical College Journal” Most women with PCOS in Kushtia are young, married housewives with symptoms like painful periods and acne, and need early checks for health issues.
June 2024 in “Bioscientia Medicina Journal of Biomedicine and Translational Research” Most children with alopecia areata have patchy hair loss and common trichoscopic features like yellow and black dots.
June 2024 in “International journal of scholarly research in biology and pharmacy” Most students believe rosemary oil, peppermint oil, amla oil, and saw palmetto can help with hair loss.
May 2024 in “International journal of medicine and psychology.” Most young people in Vladivostok view COVID-19 vaccination positively but value personal freedom and have mixed feelings about restrictions and vaccine safety.
April 2024 in “Diagnostics” Most orthodontic patients with missing teeth also have hair disorders.
April 2024 in “International Journal of Chemical and Biochemical Sciences” Most young people in Saudi Arabia use cosmetic nutritional supplements for nutrient deficiencies and appearance, but more education on proper use is needed.
Most minoxidil products on Amazon don't provide safety or side effect information.
April 2024 in “Clinical dermatology review (Print)” Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.
Most dermatologists use and find oral minoxidil effective and tolerable for hair loss treatment.
February 2024 in “Archives of Dermatological Research” Most patients know about minoxidil for hair loss, but concerns about its use and effectiveness affect their decision to use it.
February 2024 in “Actas dermo-sifiliográficas/Actas dermo-sifiliográficas” Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.